Peringkat dalam Saham
#31264
Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in... Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in developing diagnostic instruments and associated consumables for infection detection. The company crafts advanced in vitro diagnostic platforms, specifically engineered to identify infectious diseases. A key product is ASTar, an innovative system designed to rapidly assess antibiotic susceptibility in positive blood cultures. Q-linea's overarching mission is to deliver cutting-edge solutions to healthcare professionals.
Kapitalisasi Pasar
$14.06M
Perubahan (1 tahun)
-61.93%
Perdagangan Q-linea AB (publ) (QLINEA)
Harga QLINEA dengan kapitalisasi pasar B
Kapitalisasi pasar dari Q-linea AB (publ)(QLINEA)
Kapitalisasi Pasar: $14.06M
Per August 2026, Q-linea AB (publ) memiliki kapitalisasi pasar sebesar $14.06M. Ini menjadikan Q-linea AB (publ) sebagai perusahaan 31264th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Q-linea AB (publ) dari 2018 hingga 2026
QLINEA dibandingkan dengan 5 teratas stocks paling populer
| Harga QLINEA |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.460T
|
+38,835,129.32%
|
|
|
|
|
$4.489T
|
+31,931,343.07%
|
|
|
|
|
$4.141T
|
+29,451,977.53%
|
|
|
|
|
$3.569T
|
+25,381,086.47%
|
|
|
|
|
$2.798T
|
+19,900,875.38%
|
